Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Acquired Immunodeficiency Syndrome × NHS-IL12 immunocytokine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 Pancreatic Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

plerixafor 1 fludarabine phosphate 1 fludarabine 1 abemaciclib 1 Thiotepa 1 Tacrolimus 1 NHS-IL12 immunocytokine 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Melphalan 1 Maraviroc 1 Genes 1 Cyclophosphamide 1 Busulfan 1 Alemtuzumab 1 AZD 6244 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04303117 2025-08-22

NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡